Last $8.58 USD
Change Today -0.01 / -0.12%
Volume 60.0K
GNCA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard Malley M.D.

Member of Scientific Advisory Board, Genocea Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Richard Malley, also known as Rick, MD serves as an Assistant Professor of Pediatrics of Children's Hospital Boston. Dr. Malley is an expert in infectious diseases in children and an experienced Pneumococcal Researcher at Harvard Medical School. For more than a decade, he has focused on pneumococcal problems such as acquired and innate immunity, correlates of protection, mechanisms of protection from nasopharyngeal colonization, and conjugate pneumococcal vaccine trials ...

Read Full Background

Corporate Headquarters*

100 Acorn Park Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-876-8191
Fax: --

Board Members Memberships*

Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNCA:US $8.58 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
kr1.1M
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOCEA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.